- Panmolit AutoRnD (via Twitter): “Phase II trial of nonadjuvanted AKS-452 COVID-19 vaccine shows promising booster effects. Focused on the virus’s RBD, it aims to strengthen protection against emerging variants. #COVID19Vaccine #BoosterShot” (Feb. 29, 2024)
- Canton Community TV: “In the Spotlight with Tara Fleming Caruso, MA, LMHC” (Feb. 29, 2024)
- BioWorld: “In the clinic for Feb. 28, 2024” (Feb. 28, 2024)
- Jason Kraus (via Twitter): “Akston has also made significant strides in demonstrating the Ambifect® platform’s potential beyond infectious disease vaccination” (Feb. 28, 2024)
- The Rogovoy Report: “Required Reading: Woman Steps Up to Save Long-Lost Mural of 1800s Jewish Immigrant Congregation in North Adams” Feb. 26, 2024)
- BNN Breaking: “Akston Biosciences’ Groundbreaking Vaccine Study in Nature Unveils New Horizons in Immunization and Disease Treatment Explore how Akston Biosciences’ AKS-452 vaccine is revolutionizing global vaccination efforts with its stability, cost-effectiveness, and potential for therapeutic applications beyond COVID-19. Learn about the company’s dual focus on human and animal health for a brighter future in medical science” (Feb. 26, 2024)
- BioSpace: “Akston Biosciences’ AKS-452 Vaccine Study Published in Nature, Showcasing Ambifect® Platform’s Versatility” (Feb. 26, 2024)
- AP: “Akston Biosciences’ AKS-452 Vaccine Study Published in Nature, Showcasing Ambifect® Platform’s Versatility” (Feb. 26, 2024)
- StreetInsider: “Akston Biosciences’ AKS-452 Vaccine Study Published in Nature, Showcasing Ambifect® Platform’s Versatility” (Feb. 26, 2024)
- Boston Cambridge Biotech Networks (Twitter): “Akston Biosciences’ AKS-452 Vaccine Study Published in Nature, Showcasing Ambifect® Platform’s Versatility https://bcbn.org/boston-cambridge-biotech-news/2024/02/26/akston-biosciences-aks-452-vaccine-study-published-in-nature-showcasing-ambifect-platforms-versatility/?utm_source=rss&utm_medium=rss&utm_campaign=akston-biosciences-aks-452-vaccine-study-published-in-nature-showcasing-ambifect-platforms-versatility… #biotech #news” (Feb. 26, 2024)
- Boston Cambridge Biotech Networks: “Akston Biosciences’ AKS-452 Vaccine Study Published in Nature, Showcasing Ambifect® Platform’s Versatility” (Feb. 26, 2024)
- Yahoo! Finance: “Akston Biosciences’ AKS-452 Vaccine Study Published in Nature, Showcasing Ambifect® Platform’s Versatility” (Feb. 26, 2024)
- PRYZM by Ozmosi (Twitter): “Akston Biosciences’ study on AKS-452 vaccine featured in Nature highlights Ambifect® Platform’s adaptability. More Info: https://pryzm.ozmosi.com/product/20944 $XBI $IBB $XPH $PPH” (Feb. 26, 2024)
- Le Lezard: “Akston Biosciences’ AKS-452 Vaccine Study Published in Nature, Showcasing Ambifect® Platform’s Versatility” (Feb. 26, 2024)
- AI Journal: “Akston Biosciences’ AKS-452 Vaccine Study Published in Nature, Showcasing Ambifect® Platform’s Versatility” (Feb. 26, 2024)
- Amherst Bulletin: “Treasure in the attic: Woman steps up to save long-lost mural of 1800s Jewish immigrant congregation” (Feb. 23, 2024)
- Investors Ideas: “Biotech Stock News Bite – Immunic, Inc. (Nasdaq: IMUX) Year End 2023 Financial Results and Provides Corporate Update” (Feb. 23, 2024)
- Reddit: “Treasure in the attic: Woman steps up to save long-lost mural of 1800s Jewish immigrant congregation” (Feb. 20, 2024)
- Greenfield Recorder: “Treasure in the attic: Woman steps up to save long-lost mural of 1800s Jewish immigrant congregation” (Feb. 16, 2024)
- Daily Hampshire Gazette: “Treasure in the attic: Woman steps up to save long-lost mural of 1800s Jewish immigrant congregation” (Feb. 16, 2024)
- Best Stocks: “Investing in Health: The Growing Market for Allergy Therapeutics and Future Trends” (Feb. 13, 2024)
- Stocks Today: “Investing in Health: The Growing Market for Allergy Therapeutics and Future Trends” (Feb. 13, 2024)
- Outsourcing Pharma: “From a fascination with viruses to a desire to make a lasting impact, Immunic’s Hella Kohlhof shares her journey” (Feb. 7, 2024)
- Canton Community TV: “In the Spotlight: Winter Blues and Nutrition: Beth Kitzis, Clinical Dietician for NewBridge on the Charles, discusses how serotonin boosting foods can help with the winter blues and healthy nutrition” (Feb. 8-14, 2024)
- Canton Patch: “Orchard Cove Residents Provide Handmade Warmth for Project Linus” (Feb. 1, 2024)
- Newton Patch: “Orchard Cove Residents Provide Handmade Warmth for Project Linus” (Feb. 1, 2024)
- West Roxbury: Orchard Cove Residents Provide Handmade Warmth for Project Linus” (Feb. 1, 2024)
